CCA
GSK icon

Catalyst Capital Advisors’s GSK GSK Stock Holding History

Catalyst Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-508
Closed -$29K – 501
2015
Q1 		$29K Sell
508
-508
-50% -$29.1K ﹤0.01% 364
2014
Q4 		$54K Buy
+1,016
New +$56.8K 0.01% 334

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Catalyst Capital Advisors's GSK Position: Q2 2015 in Review

Catalyst Capital Advisors sold out of GSK (GSK) in Q2 2015, closing a stake of 508 shares — an estimated $29K sold.

Catalyst Capital Advisors first reported a position in GSK in Q4 2014 and held it in 2 quarters. The position peaked at $54K in Q4 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Catalyst Capital Advisors reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Catalyst Capital Advisors sold 508 GSK shares in Q2 2015, an estimated $29K.
  • Catalyst Capital Advisors first reported a position in GSK in Q4 2014 and held it in 2 quarters.
  • Catalyst Capital Advisors's GSK position peaked at $54K in Q4 2014.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.